💼With Nifty returning 25 percent and Nifty 500 returning 30 percent in Samvat 2080, investors should be happy.
💼But the 6.2% correction in October, the first above 5 percent correction in 54 months, has triggered anxiety over the market performance, going forward.
💼Of serious concern is the relentless FII selling in October amounting to Rs 113858 crores through the exchanges.
💼Given India’s elevated valuations and concerns over deceleration in earnings growth, FII selling might continue, impacting the benchmark indices.
💼In such a scenario investors should focus on stock-specific investment where Q2 results have been good and earnings visibility is bright.
💼The latest data regarding banking indicates that deposit growth has caught up with credit growth and this augurs well for banking stocks which are fairly valued.
💼Public capex is likely to pick up in H2 FY 25 and this augurs well for cement stocks.
💼Pharma stocks like Sun Pharma and Cipla have good earnings visibility.
.
.
.
#StockMarket #inflation #GeojitOutlook #MarketUpdate #InvestmentOpportunity #EmergingMarkets #StockMarket #inflation #GeojitOutlook #MarketUpdate #InvestmentOpportunity #EmergingMarkets
Posted on : 01 Nov 2024 10:32 AM